United States · FDA National Drug Code directory
NUZOLVENCE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68547-915_1835ee35-6c63-46c0-856f-6205e76af7b9
- Product NDC
- 68547-915
- Form
- FOR SUSPENSION
- Composition / generic term
- zoliflodacin
- Labeler
- La Jolla Pharmaceutical Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260401
- Source listing expiry
- 20261231
Source-listed ingredients
- ZOLIFLODACIN — 3 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 PACKET in 1 CARTON (68547-915-10) / 1 FOR SUSPENSION in 1 PACKET · 68547-915-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →